Background: Monoclonal free light chains (FLCs) frequently cause rapidly progressive renal failure in patients with multiple myeloma. Immunoassays which provide quantitative measurement of FLCs in ...
Free light chain (FLC) kappa and lambda Assays for Atellica ® NEPH 630*, BN TM II, and BN ProSpec ® Systems are developed for more reliable managment of patients with monoclonal gammopathies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback